World's Best Scientists 2026 revealed!
Award Badge
Medicine
Switzerland
2026

D-Index & Metrics

Medicine

D-Index
184
Citations
174726
World Ranking
311
National Ranking
2

Research.com Recognitions

  • 2026 - Research.com Medicine in Switzerland Leader Award
  • 2025 - Research.com Medicine in Switzerland Leader Award
  • 2023 - Research.com Medicine in Switzerland Leader Award
  • 2022 - Research.com Medicine in Switzerland Leader Award

Overview

Michael Weller is affiliated with the University of Zurich in Switzerland and has a primary research focus in the field of Medicine. Their work spans several specialized subfields, including Genetics, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Molecular Biology, and Oncology.

The scientist's research topics cover a broad spectrum of areas related to brain cancer and medical imaging. These topics include:

  • Glioma Diagnosis and Treatment
  • Brain Metastases and Treatment
  • Meningioma and schwannoma management
  • Radiomics and Machine Learning in Medical Imaging
  • Cancer Genomics and Diagnostics
  • Medical Imaging Techniques and Applications
  • Immunotherapy and Immune Responses

Weller has published extensively in prominent scientific venues. Frequent publication platforms for their work include:

  • Neuro-Oncology
  • Journal of Clinical Oncology
  • European Journal of Cancer
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Neuro-Oncology Advances

Among recent notable papers authored or co-authored by Michael Weller are:

  • EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood, 2020, Nature Reviews Clinical Oncology
  • Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma, 2020, JAMA Oncology
  • Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions, 2020, Neuro-Oncology
  • EANO guideline on the diagnosis and management of meningiomas, 2021, Neuro-Oncology
  • Single-Cell Mapping of Human Brain Cancer Reveals Tumor-Specific Instruction of Tissue-Invading Leukocytes, 2020, Cell

Weller collaborates frequently with several other researchers in the field. The most common co-authors include:

  • Martin J. van den Bent
  • Émilie Le Rhun
  • Matthias Preusser
  • Patrick Y. Wen
  • Patrick Roth

Best Publications

  • Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

    Roger Stupp;Warren P. Mason;Martin J. van den Bent;Michael Weller

  • Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

    Roger Stupp;Monika E. Hegi;Warren P. Mason;Martin J. van den Bent

  • MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma

    Monika E Hegi;Annie-Claire Diserens;Thierry Gorlia;Marie-France Hamou

  • DNA methylation-based classification of central nervous system tumours

    David Capper;David Capper;David Capper;David T. W. Jones;Martin Sill;Volker Hovestadt

  • Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial

    Roger Stupp;Roger Stupp;Roger Stupp;Sophie Taillibert;Sophie Taillibert;Andrew Kanner;William Read;William Read

  • An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor

    Christiane A. Opitz;Ulrike M. Litzenburger;Ulrike M. Litzenburger;Felix Sahm;Martina Ott

  • Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.

    Christian Hartmann;Christian Hartmann;Jochen Meyer;Jörg Balss;David Capper

  • Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial

    Wolfgang Wick;Michael Platten;Christoph Meisner;Joerg Felsberg

  • EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood.

    Michael Weller;Martin van den Bent;Matthias Preusser;Emilie Le Rhun

  • Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

    Roger Stupp;Roger Stupp;Monika E Hegi;Thierry Gorlia;Sara C Erridge

  • Current state of immunotherapy for glioblastoma

    Michael Lim;Yuanxuan Xia;Chetan Bettegowda;Michael Weller

  • Long-term survival with glioblastoma multiforme

    Dietmar Krex;Barbara Klink;Christian Hartmann;Andreas Von Deimling

  • Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: Implications for classification of gliomas

    Christian Hartmann;Christian Hartmann;Bettina Hentschel;Wolfgang Wick;Wolfgang Wick;David Capper

  • Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial

    David A. Reardon;Alba A. Brandes;Antonio Omuro;Paul Mulholland

  • Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo.

    Simone Fulda;Wolfgang Wick;Michael Weller;Klaus Michael Debatin;Klaus Michael Debatin

  • Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity

    Monika E. Hegi;Lili Liu;James G. Herman;Roger Stupp

  • Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma

    Roger Stupp;Roger Stupp;Roger Stupp;Sophie Taillibert;Sophie Taillibert;Andrew Kanner;William Read;William Read

  • European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas

    Michael Weller;Martin van den Bent;Jörg C Tonn;Roger Stupp

  • NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide

    Wolfgang Wick;Christian Hartmann;Corinna Engel;Mandy Stoffels

  • Lomustine and Bevacizumab in Progressive Glioblastoma

    Wolfgang Wick;Thierry Gorlia;Martin Bendszus;Martin Taphoorn

Frequent Co-Authors

Wolfgang Wick
Wolfgang Wick German Cancer Research Center
Guido Reifenberger
Guido Reifenberger Heinrich Heine University Düsseldorf
Andreas von Deimling
Andreas von Deimling Heidelberg University
Roger Stupp
Roger Stupp Northwestern University
Martin J. van den Bent
Martin J. van den Bent Erasmus University Rotterdam
Johannes Dichgans
Johannes Dichgans University of Tübingen
Felix Sahm
Felix Sahm University Hospital Heidelberg
Manfred Westphal
Manfred Westphal Universität Hamburg
Stefan M. Pfister
Stefan M. Pfister German Cancer Research Center
David Capper
David Capper Charité - University Medicine Berlin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're exploring a career in medicine but want more flexible or alternative options, there are several online degree pathways that offer excellent opportunities. For those already in the nursing field, earning an online phd nursing can open doors to advanced research, teaching, and leadership roles. This is ideal for professionals seeking the highest level of nursing education without sacrificing their current commitments.

Students or working nurses looking to advance more affordably might consider enrolling in cheap rn to bsn online programs to increase their career prospects and earning potential. Even if your background isn't in nursing, you can transition with direct entry msn programs for non-nursing majors, which provide a fast-track bridge into the profession for bachelor’s degree holders from other disciplines.

For those concerned about admission barriers, some schools offer an easiest bsn program to get into, making the healthcare field more accessible than ever. By considering these related online programs, you can find flexible ways to pursue a rewarding healthcare career without following the traditional medical degree path.

Best Scientists Citing Michael Weller

Trending Scientists